ClinicalTrials.govpublic full text
Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant
hiv infections, renal transplant rejection, hiv positive, post renal transplant, bictegravir/emtricitabine/tenofovir alafenamide, antiretroviral, biktarvy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903032
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.